(Q38974852)

8 September 2017

title

Clinical significance of GAB2, a scaffolding/docking protein acting downstream of EGFR in human colorectal cancer (English)

1 reference

8 September 2017

1 reference

17

Masaki Mori

1 reference

8 September 2017

16

Yuichiro Doki

1 reference

8 September 2017

13

Hidetoshi Eguchi

1 reference

8 September 2017

15

Hirofumi Yamamoto

1 reference

8 September 2017

5

Genta Sawada

1 reference

8 September 2017

11

Junji Kurashige

1 reference

8 September 2017

1

Tae Matsumura

1 reference

8 September 2017

4

Ryutaro Uchi

1 reference

8 September 2017

9

Hiroki Ueo

1 reference

8 September 2017

14

Tomoya Sudo

1 reference

8 September 2017

2

Keishi Sugimachi

1 reference

8 September 2017

18

Koshi Mimori

1 reference

8 September 2017

7

Hidenari Hirata

1 reference

8 September 2017

8

Shotaro Sakimura

1 reference

8 September 2017

12

Yoshiaki Shinden

1 reference

8 September 2017

Yusuke Takahashi

3

1 reference

8 September 2017

Masami Ueda

series ordinal

6

1 reference

8 September 2017

Yuki Takano

series ordinal

10

1 reference

8 September 2017

publication date

17 July 2014

1 reference

Annals of Surgical Oncology

8 September 2017

published in

1 reference

8 September 2017

volume

21 Suppl 4

1 reference

8 September 2017

page(s)

S743-9

1 reference

https://scigraph.springernature.com/pub.10.1245/s10434-014-3889-x

8 September 2017

exact match

0 references

cites work

Global burden of cancer in 2008: a systematic analysis of disability-adjusted life-years in 12 world regions.

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3889-X

The quest to overcome resistance to EGFR-targeted therapies in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3889-X

EGFR antagonists in cancer treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3889-X

The "Gab" in signal transduction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3889-X

Function, regulation and pathological roles of the Gab/DOS docking proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3889-X

Participation of both Gab1 and Gab2 in the activation of the ERK/MAPK pathway by epidermal growth factor

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3889-X

Gab2 phosphorylation by RSK inhibits Shp2 recruitment and cell motility

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3889-X

Blockade of epidermal growth factor- or heregulin-dependent ErbB2 activation with the anti-ErbB2 monoclonal antibody 2C4 has divergent downstream signaling and growth effects

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3889-X

GAB2--a scaffolding protein in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3889-X

A role for the scaffolding adapter GAB2 in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3889-X

The GAB2 signaling scaffold promotes anchorage independence and drives a transcriptional response associated with metastatic progression of breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3889-X

GAB2 induces tumor angiogenesis in NRAS-driven melanoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3889-X

Gab2 regulates the migratory behaviors and E-cadherin expression via activation of the PI3K pathway in ovarian cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3889-X

Focal amplification and oncogene dependency of GAB2 in breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3889-X

Gab2-mediated signaling promotes melanoma metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3889-X

GAB2 amplifications refine molecular classification of melanoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3889-X

Gab2 regulates cytoskeletal organization and migration of mammary epithelial cells by modulating RhoA activation

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3889-X

Role of Gab2 in mammary tumorigenesis and metastasis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3889-X

Metastasis-Associated Gene Expression Changes Predict Poor Outcomes in Patients with Dukes Stage B and C Colorectal Cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3889-X

Oncogenic pathway signatures in human cancers as a guide to targeted therapies

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3889-X

Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3889-X

GISTIC2.0 facilitates sensitive and confident localization of the targets of focal somatic copy-number alteration in human cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3889-X

Disrupting the scaffold to improve focal adhesion kinase-targeted cancer therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3889-X

PIK3CA overexpression is a possible prognostic factor for favorable survival in ovarian clear cell carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3889-X

Molecular analysis of the PI3K-AKT pathway in uterine cervical neoplasia: frequent PIK3CA amplification and AKT phosphorylation

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3889-X

Involvement of PI3K/Akt pathway in cell cycle progression, apoptosis, and neoplastic transformation: a target for cancer chemotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3889-X

Overexpression of the oncogenic signal transducer Gab2 occurs early in breast cancer development

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3889-X

GAB2 is a novel target of 11q amplification in AML/MDS

21 January 2018

1 reference

https://api.crossref.org/works/10.1245%2FS10434-014-3889-X

10.1245/S10434-014-3889-X

21 January 2018

Identifiers

DOI

1 reference

Dimensions Publication ID

8 September 2017

1003435726

0 references

1 reference